BioSpace News Archive

The National Comprehensive Cancer Network® published its first ever set of treatment recommendations pertaining to neuroblastoma.

Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company, announced a Notice of Allowance for a second US patent for its Phase 3-ready product, ST-62516 (trimetazidine), a cardiorenal metabolic modulator.

TuHURA Biosciences, Inc. announced the appointment of Dr. Dennis Yamashita as Chief Scientific Officer and Head of Discovery Research and Early Development.

ORTHOSON, a medtech innovator developing a portfolio of novel treatments for back pain, today announced that its Bio-Structural Gel product has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

BioNxt Solutions Inc. is pleased to report that the toxicity study for its oral dissolvable film based proprietary Cladribine product for the treatment of Multiple Sclerosis has been completed and results received by the Company.

Alleo Labs announced a recent publication entitled “Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics” published online in the peer reviewed Journal of Pharmaceuticals on January 25, 2024.

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in neurovascular care.

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.

Cumulus Neuroscience has been recognized by GOOD DESIGN® Awards, in the medical category for the product design of its first-in-class electroencephalogram headset.

Skye Bioscience, Inc. today announced that it will present an overview of the company and its programs in obesity and glaucoma at the 34th Annual Oppenheimer Healthcare Life Sciences Conference.